Growth Metrics

Medicale (MCLE) Liabilities and Shareholders Equity (2020 - 2024)

Medicale (MCLE) has disclosed Liabilities and Shareholders Equity for 5 consecutive years, with $159.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Liabilities and Shareholders Equity changed 0.0% year-over-year to $159.0, compared with a TTM value of $159.0 through Sep 2025, down 75.0%, and an annual FY2024 reading of $159.0, changed 0.0% over the prior year.
  • Liabilities and Shareholders Equity was $159.0 for Q4 2024 at Medicale, roughly flat from $159.0 in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $34900.0 in Q1 2021 and bottomed at $159.0 in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $7035.3, with a median of $159.0 recorded in 2022.
  • The sharpest move saw Liabilities and Shareholders Equity rose 8.44% in 2021, then plummeted 98.74% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $11600.0 in 2020, then rose by 8.44% to $12579.0 in 2021, then plummeted by 98.74% to $159.0 in 2022, then changed by 0.0% to $159.0 in 2023, then changed by 0.0% to $159.0 in 2024.
  • Business Quant data shows Liabilities and Shareholders Equity for MCLE at $159.0 in Q4 2024, $159.0 in Q3 2024, and $159.0 in Q2 2024.